Chef Anahita Naderi

Marcy Graham.

Marcy Graham, Ambit's Executive Director of Investor Relations, will provide an review of the Company and its lead drug candidate, quizartinib, at 9:00 a.m click here . On Wednesday ET, March 12, 2014, accompanied by a breakout session at 9:30am. Designed by a team of geneticists and genetic counselors with years of medical and laboratory experience, the panel is definitely a responsible and ethical method of identifying individuals at high risks to get a child with serious genetic conditions. As with all scientific assays performed by Ambry Genetics, your physician must purchase the test.